Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Abraxane paclitaxel: Phase III started

ABBI began an open-label Phase III trial in 1,000 Stage IIIb and IV

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE